期刊文献+

血管紧张素Ⅰ转换酶基因多态性与2型糖尿病肾病相关性研究 被引量:7

Association between angiotensin Ⅰ converting enzyme gene insertion/deletion polymorphism and Type 2 diabetes nephropathy
暂未订购
导出
摘要 目的 探讨血管紧张素Ⅰ转换酶 (ACE)基因插入 /缺失 (I/D)多态性与 2型糖尿病肾病发生和发展的关系。方法 对 2 98例 2型糖尿病患者 (T2DM总组 )和 87名非糖尿病正常人 (Non DM组 )进行病例对照研究。将T2DM总组分为无糖尿病肾病 (DN 0 )组和糖尿病肾病 (TDN)组 ,后者进一步分为微量蛋白尿 (DN 1)组和临床蛋白尿 (DN 2 )组。采用聚合酶链反应 4 %琼脂糖凝胶电泳法检测ACE基因内含子 16的 1个 2 87bp的Alu顺序I/D型多态标志。结果 ① 2型糖尿病未合并肾病与合并肾病及肾功能不全等各亚组之间基因型频率的差异无显著性 (DN 0、DN 1和DN 2组DD∶DI∶II别为 2 7.5 %∶4 3.8%∶2 8.8%、2 3.3%∶39.5 %∶37.2 %和2 2 .5 %∶4 7.2 %∶30 .3% )。②基因型组合DD +DI与II各组间比较的差异无显著性。③等位基因频率的差异无显著性 (DN 0、DN 1和DN 2组D∶I分别为 4 9.4 %∶5 0 .6 %、4 3.0 %∶5 7.0 %和 4 6 .1%∶5 3.9% )。结论 ACEI/D多态性与 Objective To investigate whether ACE gene I/D polymorphism is a predictor of onset and progression of diabetic nephropathy.Methods A case-control study for a total of 385 Chinese subjects including 298 patients with type 2 diabetes mellitus(T2DM) and 87 non-diabetes(Non-DM) for controls were performed. The T2DM group was subdivided into non- diabetic nephropathy(DN-0; n=80) and diabetic nephropathy(TDN; n=218) groups. The latter group was further subdivided into microalbuminuric nephropathy(DN-1; n=129)group and severe diabetic nephropathy(DN-2; n=89) group. The ACE gene insertion/deletion polymorphism was determind by PCR- 4% agarose gel electrophoresis.Results ①No significant difference in genotype distribution among the DN-0, DN-1 and DN-2 groups (DD∶DI∶II=27.5%∶43.8%∶28.8%/ 23.3%∶39.5%∶37.2%/ 22.5%∶47.2%∶30.3%, P>0.05) were observed. ②There was no significant difference between DD+DI and II (P>0.05). ③There was also no difference in allelic frequencies among all groups(P>0.05).Conclusion ACE gene I/D polymorphism is not associated with the development of Type 2 diabetic nephropathy among Chinese.
出处 《上海医学》 CAS CSCD 北大核心 2004年第7期457-459,共3页 Shanghai Medical Journal
基金 国家自然科学基金资助项目 ( 3 990 0 0 71)
关键词 血管紧张素Ⅰ转换酶 基因多态性 2型糖尿病肾病 2型糖尿病 聚合酶链反应 琼脂糖凝胶电泳法 Type 2 diabetes Diabetic nephropathy Angiotensin 1 converting enzyme gene insertion/deletion polymorphism
  • 相关文献

参考文献16

  • 1Schmidt S, Ritz E. Genetic determinants of diabetic renal disease and their impact on therapeutic intervention. Kidney Int Suppl,1997, 63: S27-S31.
  • 2Strojek K, Gizeszczak W, Rudzki H, et al. Does an association between angiotensin I converting enzyme gene polymorphism and the prevalence of diabetic nephropathy in patients with diabetes type Ⅱ exist? Pol Arch Med Wewn, 1995, 94: 214-218.
  • 3Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997, 20:1183-1197.
  • 4Hubert C, Houot AM, Corvol P, et al. Structure of the angiotensin 1-converting enzyme gene. J Biol Chem, 1991, 266:15377-15383.
  • 5Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 1990, 86: 1343-1346.
  • 6Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkages analysis, that a variant of the angiotensin I-converting enzyme(ACE) gene controls plasma ACE levels. Am J Hum Genet, 1992, 51: 197-205.
  • 7Perna A, Ruggenenti P, Testa A, et al. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathiesl. Kidney Int, 2000, 57: 274-281.
  • 8Ha SK, Yong Lee S, Su Park HS, et al. ACE DD genotype is more susceptible than ACE Ⅱ and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric noninsulin-dependent diabetes mellitus. Nephrol Dial Transplant,2000, 15: 1
  • 9Marre M, Bernadet P, Gallois Y, et al. Relationships between angiotensin 1 converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications, Diabetes, 1994,43: 384-388.
  • 10Fava S, Azzopardi J, Ellard S, et al. ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and estab lished renal disease. Diabetes Care, 2001, 24: 2115-2120.

二级参考文献3

  • 1项坤三,中华内分泌代谢杂志,1995年,11卷,201页
  • 2Dr. C. Nishimura,T. Saito,T. Ito,Y. Omori,T. Tanimoto. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients[J] 1994,Diabetologia(3):328~330
  • 3Alexander Graham,Paul Heath,John E. N. Morten,Alexander F. Markham. The human aldose reductase gene maps to chromosome region 7q35[J] 1991,Human Genetics(5):509~514

共引文献348

同被引文献88

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部